Evaluation of the effect of glutathione on cisplatin antitumor activity and kidney injury at different administration times

Author：          

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.6, Iss.5, 2012-01, pp. : 1075-1080

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antitumor effects of different administration sequences of cisplatin and Endostar on Lewis lung carcinoma

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 822-828

Spandidos Publications

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of YM155, a selective survivin suppressant, in combination with cisplatin in hepatoblastoma

By            

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 407-414

Spandidos Publications

Access to resources Recommend Favorite

Effects of Recombinant Human Erythropoietin on the Antitumor Effect of Cisplatin in SCID Mice Bearing Human Ovarian Cancer: A Possible Oxygen Effect

By Silver D.F.   Piver M.S.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 280-284

Elsevier

Access to resources Recommend Favorite

Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis

By      

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4561-4566

Spandidos Publications

Access to resources Recommend Favorite